4.7 Article

Anesthetic pentobarbital inhibits proliferation and migration of malignant glioma cells

Journal

CANCER LETTERS
Volume 282, Issue 1, Pages 35-42

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2009.02.055

Keywords

Pentobarbital; Malignant glioma; Proliferation; Migration; Cell cycle; MAPK

Categories

Funding

  1. National Natural Science Foundation of China [30830111, 330801408]
  2. National Natural Science Foundation of Guangdong Province [8451008901000297]

Ask authors/readers for more resources

Malignant gliomas are common and aggressive brain tumors in adults. The rapid proliferation and diffuse brain migration are main obstacles to successful treatment. Here we show that pentobarbital, a central depressant introduced clinically a century ago, is capable of suppressing proliferation and migration of C6 malignant glioma cells in a concentration-dependent manner. Pentobarbital also leads to a G1 phase cell cycle arrest accompanied by suppressed G1 cell cycle regulatory proteins Cyclin D1, Cyclin D3, CDK2 and phosphorylated Rb. In addition, noticeable morphological changes and interrupted alpha-tubulin microtubule assembly are induced by pentobarbital exposure. Intracellular signal pathways involved in the effect of pentobarbital is concerned with inactivation of ERK, c-Jun and Akt. Together, these findings suggest anti-proliferation and anti-migration effects of pentobarbital on malignant gliomas, most likely by arresting cell cycle and interfering microtubule. ERK, c-Jun MAPK and PI3K/Akt are possible signaling pathways involved. (C) 2009 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available